US Patent 11001619 GIP agonist compounds and methods
Patent 11001619 was granted and assigned to Zealand Pharma A/S on May, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+158 characters)
Article
Patent abstract
The present invention relates to acylated GIP analogues which have GIP agonist activity, and their use in the treatment of metabolic disorders.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Anne Pernille Tofteng Shelton0
Bjarne Due Larsen0
Jacob Ulrik Fog0
Maria Alexandrovna Deryabina0
Pia Nørregaard0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
US Patent 11001619 GIP agonist compounds and methods
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11001619
Date of patent
May 11, 2021
Patent application number
16281347
Date Filed
February 21, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11001619 GIP agonist compounds and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
